BamSEC and AlphaSense Join Forces
Learn More

Tourmaline Bio Inc.

NASDAQ: TRML    
Share price (12/23/24): $21.30    
Market cap (12/23/24): $546 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 19 pages Amended and Restated Bylaws of Tourmaline Bio, Inc
12/34/56
EX-3.1
from 10-Q 13 pages Third Amended and Restated Certificate of Incorporation of Talaris Therapeutics, Inc
12/34/56
EX-3.3
from 8-K 2 pages Certificate of Amendment to the Third Amended and Restated Certificate of Incorporation of Talaris Therapeutics, Inc
12/34/56
EX-3.2
from 8-K 3 pages Certificate of Amendment to the Third Amended and Restated Certificate of Incorporation of Talaris Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 3 pages Certificate of Amendment to the Third Amended and Restated Certificate of Incorporation of Talaris Therapeutics, Inc
12/34/56
EX-3.3
from S-4 25 pages Bylaws of Tourmaline Bio, Inc
12/34/56
EX-3.2
from S-4 19 pages Amended and Restated Certificate of Incorporation of Tourmaline Bio, Inc
12/34/56
EX-3.1
from S-4 2 pages Certificate of Amendment to Amended and Retated Certificate of Incorporation of Tourmaline Bio, Inc
12/34/56
EX-3.2
from 8-K 26 pages Amended and Restated Bylaws of Talaris Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 10 pages Third Amended and Restated Certificate of Incorporation of Talaris Therapeutics, Inc
12/34/56
EX-3.4
from S-1/A 26 pages Amended and Restated Bylaws of Talaris Therapeutics, Inc
12/34/56
EX-3.2
from S-1/A 9 pages Third Amended and Restated Certificate of Incorporation of Talaris Therapeutics, Inc
12/34/56
EX-3.1
from S-1/A 33 pages Second Amended and Restated Certificate of Incorporation of Talaris Therapeutics, Inc
12/34/56
EX-3.3
from S-1 21 pages Amended and Restated Bylaws of Talaris Therapeutics, Inc. a Delaware Corporation Effective September 22, 2020
12/34/56
EX-3.1
from S-1 30 pages Second Amended and Restated Certificate of Incorporation of Talaris Therapeutics, Inc
12/34/56
EX-3.3
from DRS 21 pages Amended and Restated Bylaws of Talaris Therapeutics, Inc. a Delaware Corporation Effective September 22, 2020
12/34/56
EX-3.1
from DRS 30 pages Second Amended and Restated Certificate of Incorporation of Talaris Therapeutics, Inc
12/34/56